BECN1 and prostate carcinoma: Paclitaxel treatment has also been found to induce autophagy in A549 cells, U87 glioma cells, human PC-3 prostate cancer and colon HT-29 cancer cells via the increasing expression levels of LC3-II, ATG5 and Beclin1 in a dose-dependent manner.